BioMarin to Host Third Quarter 2025 Financial Results Conference Call and Webcast on Monday, October 27, 2025, at 4:30pm ET

Rhea-AI Summary

BioMarin (NASDAQ: BMRN) announced a conference call and webcast with Alexander Hardy, president and CEO, on Monday, October 27, 2025 at 4:30 p.m. ET to discuss third quarter 2025 financial results and provide a general business update.

Dial-in numbers are provided for U.S./Canada and international participants, and a live audio webcast will be available via the investor site at https://investors.biomarin.com/. A replay will be archived on the site for one week following the call.

SAN RAFAEL, Calif., Oct. 22, 2025 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Alexander Hardy, President and Chief Executive Officer of BioMarin, will host a conference call and webcast on Monday, October 27, 2025, at 4:30 p.m. ET to discuss third quarter 2025 financial results and provide a general business update.

Dial-in Number 
U.S. / Canada Dial-in Number: 800-715-9871
International Dial-in Number: 646-307-1963
Conference Call ID: 4998437 

U.S. / Canada Replay Dial-in Number: 800-770-2030
International Replay Dial-in Number: 609-800-9909
Playback ID: 4998437 

Interested parties may access a live audio webcast of the conference call via the investor section of the BioMarin website, https://investors.biomarin.com/. A replay of the call will be archived on the site for one week following the call.

About BioMarin
BioMarin is a global biotechnology company dedicated to translating the promise of genetic discovery into medicines that make a profound impact on the life of each patient. The San Rafael, California-based company, founded in 1997, has a proven track record of innovation with eight commercial therapies and a strong clinical and preclinical pipeline. Using a distinctive approach to drug discovery and development, BioMarin pursues treatments that offer new possibilities for patients and families around the world navigating rare or difficult-to-treat genetic conditions. To learn more, please visit www.biomarin.com. 

Contacts:
Investors	Media
Traci McCarty	Marni Kottle
BioMarin Pharmaceutical Inc.	BioMarin Pharmaceutical Inc.
(415) 455-7558	(650) 374-2803

View original content to download multimedia:https://www.prnewswire.com/news-releases/biomarin-to-host-third-quarter-2025-financial-results-conference-call-and-webcast-on-monday-october-27-2025-at-430pm-et-302590758.html

SOURCE BioMarin Pharmaceutical Inc.

FAQ

When will BioMarin (BMRN) discuss its third quarter 2025 results?

BioMarin will hold a conference call and webcast on October 27, 2025 at 4:30 p.m. ET.

Who will host the BioMarin (BMRN) Q3 2025 earnings call?

The call will be hosted by Alexander Hardy, president and chief executive officer.

How can investors access the BioMarin (BMRN) earnings webcast on October 27, 2025?

Access the live audio webcast via the investor section at https://investors.biomarin.com/.

What are the dial-in numbers for the BioMarin (BMRN) October 27, 2025 conference call?

U.S./Canada dial-in is 800-715-9871; international dial-in is 646-307-1963; Conference ID 4998437.

Will there be a replay of the BioMarin (BMRN) Q3 2025 call and for how long?

Yes. A replay will be archived on the investor site for one week after the call; replay dial-ins are provided.

Where can I find the replay dial-in numbers for the BioMarin (BMRN) October 27 call?

U.S./Canada replay dial-in is 800-770-2030; international replay dial-in is 609-800-9909; playback ID 4998437.